DISEASE SCANNER
Global Incurable Diseases Tracker
Cirrhosis
End-stage liver disease characterized by replacement of normal hepatic architecture with fibrosis and regenerative nodules. Results from chronic liver injury. Irreversible but progression can be halted.
120.0M
111
Symptoms
Treatment Options
Risk Factors
Diagnostic Methods
- 1Liver function tests
- 2Coagulation studies
- 3Complete blood count
- 4Abdominal ultrasound/CT/MRI
- 5Elastography (FibroScan)
- 6Liver biopsy (gold standard)
- 7Endoscopy (varices)
- 8Serum ammonia
Prognosis
Child-Pugh and MELD scores predict survival. 5-year survival: Child A 85-90%, Child B 60-80%, Child C 35-45%. Hepatocellular carcinoma risk 3-5%/year. Liver transplant 5-year survival 70-80%.
Prevention
- Hepatitis B vaccination
- Hepatitis C treatment
- Alcohol moderation/cessation
- NAFLD prevention (weight, exercise)
- Regular screening for liver cancer
- Avoiding hepatotoxins
Research Status
Non-selective beta-blockers (propranolol, nadolol) for variceal prophylaxis. TIPS procedure for refractory ascites. Liver transplantation definitive treatment. Artificial liver support devices. Antifibrotic therapies in development. Stem cell therapy research.
Affected Countries
Sources
- https://www.cdc.gov/
- https://www.hematology.org/education/patients
- https://www.ncbi.nlm.nih.gov/books
- https://rarediseases.org/rare-diseases
Medical Disclaimer
This information is for educational purposes only. Always consult healthcare professionals for medical advice, diagnosis, and treatment.